|本期目录/Table of Contents|

[1]王静,谭擎缨,阮勇,等.2型糖尿病患者体脂含量及分布与血清内脂素水平的相关研究[J].医学研究与战创伤救治(原医学研究生学报),2014,16(05):465-468.[doi:10.3969/j.issn.1672-271X.2014.05.006]
　WANG Jing,TANG Qing-ying,RUAN Yong,et al.The relationship of visfatin with body fat content and fat distribution in type 2 diabetes[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2014,16(05):465-468.[doi:10.3969/j.issn.1672-271X.2014.05.006]
点击复制

2型糖尿病患者体脂含量及分布与血清内脂素水平的相关研究()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第16卷
期数:
2014年05期
页码:
465-468
栏目:
出版日期:
2014-09-20

文章信息/Info

Title:
The relationship of visfatin with body fat content and fat distribution in type 2 diabetes
作者:
王静; 谭擎缨; 阮勇; 阮芸; 王秀景; 王惠玲; 姚佳琦
310013浙江杭州，解放军117医院内分泌科
Author(s):
WANG Jing; TANG Qing-ying; RUAN Yong; RUAN Yun; WANG Xiu-jing; WANG Hui-lin; YAO Jia-qi.
Department of Endocrinology，117 Hospital of PLA ，Hangzhou，Zhejiang 310013，China
关键词:
2型糖尿病; 内脂素; 脂肪组织
Keywords:
type 2 diabetes mellitus;  visfatin;  adipose tissue
分类号:
R587.1
DOI:
10.3969/j.issn.1672-271X.2014.05.006
文献标志码:
A
摘要:
目的探讨2型糖尿病(T2DM)患者体脂含量及分布与血清内脂素水平的关系。方法选择2012年10月-2013年9月收治的119例T2DM患者作为研究对象。测定腹内脂肪面积(VFA)、 腹部皮下脂肪面积(SFA)、血清内脂素(visfatin)、游离脂肪酸(FFA)、空腹胰岛素(FINS)和相关的临床指标，计算胰岛素抵抗指数(HOMA-IR)和腰臀比(WHR)。根据VFA的四分位数法 分为A、B、C和D组。比较4组间的血清内脂素水平，并对VFA与内脂素、FFA等指标行相关性分析。结果C和D组的内脂素、FFA、FINS水平显著高于A和B组，随着VFA增加，内脂素水平 也显著增加。内脂素与BMI、WHR、FFA、HOMA-IR、FINS、TG、VFA、SFA均存在一定的相关关系(r分别为0.426、0.501、0.704、0.477、0.465、0.211、0.508、0.185，P＜0.05)， 在校正SFA、BMI、WHR、FFA、HOMA-IR、FINS、TG的影响后，偏相关系数(r)为0.291(P﹤0.01)。多元线性逐步回归分析以内脂素为因变量，以BMI、WHR、FFA、HOMA-IR、FINS、 TG、VFA、SFA为自变量，显示VFA、FFA、WHR是内脂素的独立相关因素。结论2型糖尿病患者体脂含量和分布影响血清内脂素水平，内脂素与VFA呈显著正相关(r=0.508,P﹤0.01)。
Abstract:
Objective To study the relationship of visfatin with body fat content and fat distribution in type 2 diabetes.Methods We collected the clinical data,abdominal visceral fat area(VFA),abdominal subcutaneous fat area(SFA),free fatty acid(FFA),FINS and related clinical variables of type 2 diabetic inpatients at our hospital.And HOMA-IR,WHR were calculated.According to the puartile of VFA,the subjects were divided into A,B,C and D groups.And their profiles were compared with regards to the level of visfatin.Their relative intensities of VFA and visfatin were analyzed.Results Visfatin,FFA and FINS of group C and D were larger than that of group A and B.With the rising level of VFA,the level of visfatin increased.There are some correlation between visfatin and BMI,WHR,FFA,HOMA-IR,FIns,TG,VFA,SFA (r=0.426 0.501,0.704,0.477,0.465,0.211,0.508,0.185，P＜0.05).After SFA,BMI,WHR,FFA,HOMA-IR,FIns and TG adjusting,partial correlation coefficient of 0.291 (P< 0.01).Multiple regression analysis showed that VFA,FFA and WHR were independent related factors for influencing the serum visfatin level.Conclusion Serum level of visfatin is affected by body fat content or fat distribution in type 2 diabetes.Visfatin has a positive relationship with VFA.

参考文献/References:

[1]Xu Y,Wang L,He J，et al.Prevalence and control of diabetes in Chinese adults［J］.JAMA，2013,310(9):948-959.
[2］周海翔.肥胖合并2型糖尿病患者的特征分析——基于患者的临床分析［J］.中国糖尿病杂志，2013,21(6):575-576.
[3］Alberti KG,Zimmet PZ.Definition,diagnosis and classification of diabetes mellitus and its complications.Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation［J］.Diabet Med，1998,15(7):539-553.
[4］翟莎，王战建.2型糖尿病患者腹腔内脏脂肪面积与尿白蛋白排泄率的相关性分析［J］.中华医学杂志，2011，91(30)：2108-2111.
[5］Fukuhara A,Matsuda M,Nishizawa M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of insulin［J］.Science，2005,307(5708):426- 430.
[6］Dogrua T,Sonmeza A,Tascia I,et al.Plasma visfatin levels in patients with new diagnosed and untreated type 2 diabetesmrllitus and impaired glucose tolerance［J］.Diabetes Res Clin Pract,2007,76(1):24-29.
[7］Haider DG,Holzer G,Schaller G.The adipokine visfatin is markedly elevated in obese children［J］.J Pediatr Gastroenterol Nutr，2006,43(4):548-649.
[8］Haider DG,Schindler K,Schaller G,et al.Increased plasma visfatin concentrations in morbidly obses subjects are reduced after gastric banding［J］.J Clin Endocrinol Metab,2006,91(4):1578-1581.
[9］Araki S,Dobashi K,Kubo K,et al.Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obses children［J］.Obesity(Silver Spring),2008,16(2):384-388.
[10］Garcia-Fuentes E,Garcia-Almeida JM,Garcia-Arnes J,et al.Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass ［J］.Obesity，2007,15(10):2391-2395.
[11］Chen MP,Chung DM,Chang DM,et al.Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patient with type 2 diabetes mellitus［J］.J Clin Endocrinol Metab，2006,91(1):295-299.
[12］Chang Y,Chang T,Lee W,et al.The relationship of visfatin/pre-B cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation,insulin resistance,and plasma lipid［J］.Metabolism，2010,59(1):93-99.
[13］王荔华，黄昭穗，黄胜利，等.老年2型糖尿病体脂状态及其与慢性并发症相关因素的调查分析和健康管理研究［J］.东南国防医药，2003，5(3)：172-174.
[14］Miyawaki T,Abe M,Yahata K,et al.Contribution of visceral fat accumulation to the risk factors for atheosclerosis in non-obese Japanese［J］.Intern Med,2004,43(12):1138-1144.
[15］Mori Y,Hoshino K,Yokata K,et al.Differences in the pathology of the metabolic syndrome with or without visceral fat accumulation:a study in prediabetic Japanese middle-aged men［J］.Endocrine，2006,29(1):149-153.
[16］黄艳，赵亚萍，王加林，等.肥胖相关胰岛素抵抗分子机制的研究进展［J］.东南国防医药，2010，12(6)：526-529.
[17］Moschen AR,Kaser A,Enrich B,et al.Visfatin,a adipocytokine with proinflammatory and immunomodulating properties［J］.J Immunol，2007,178(3):1748-1758.

相似文献/References:

[1]潘全民.老年2型糖尿病患者步行前后血糖变化分析[J].医学研究与战创伤救治(原医学研究生学报),2013,15(05):525.[doi:10.3969/j.issn.1672-271X.2013.05.039]
[2]杜振双,张诚华.BillrothⅡ式胃切除术对患者血糖的影响[J].医学研究与战创伤救治(原医学研究生学报),2013,15(01):62.
[3]王佳薇,李 冰,郑玲玉.2型糖尿病158例临床路径护理分析[J].医学研究与战创伤救治(原医学研究生学报),2012,14(02):168.
[4]王加林,王 猛,杨文娟,等.131I治疗甲状腺功能亢进症合并2型糖尿病101例[J].医学研究与战创伤救治(原医学研究生学报),2011,13(02):109.
　WANG Jia-lin,WANG Meng,YANG Wen-juan,et al.Clinical study of 131I on the treatment of 101 cases of hyperthyroidism patients with type 2 diabetes mellitus[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2011,13(05):109.
[5]何述莉,董立新,施能彬,等.检测2型糖尿病患者尿微量白蛋白的临床意义[J].医学研究与战创伤救治(原医学研究生学报),2009,11(03):255.
[6]王 静,阮 芸,谭擎缨,等.α-酮酸在早期2型糖尿病肾病治疗中 的作用[J].医学研究与战创伤救治(原医学研究生学报),2008,10(06):426.
　WANG Jing,RUAN Yun,TAN Qing-ying,et al.The effect of α-keto acid on early diabetic nephropathy in type 2 diabetes mellitus[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2008,10(05):426.
[7]王 静,彭永平,宫剑滨,等.前列地尔对冠心病合并糖尿病患者介入治疗后造影剂肾病的影响[J].医学研究与战创伤救治(原医学研究生学报),2014,16(01):28.
　WANG Jing,PENG Yong-ping,GONG Jian-bin,et al.Effect of alprostadil on contrast-induced nephropathy in coronary heart disease patients with type 2 diabetes undergoing percutaneous coronary intervention[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2014,16(05):28.
[8]王爱民,徐向进,熊晓琴,等.2型糖尿病患者长期家庭血糖监测的随访分析[J].医学研究与战创伤救治(原医学研究生学报),2014,16(01):40.
　WANG Ai-min,XU Xiang-jin,XIONG Xiao-qin,et al.Following-up and nursing patients with type 2 diabetes mellitus by a long-term blood glucose monitoring at home[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2014,16(05):40.
[9]熊晓琴,王爱民,罗晶,等.血糖负荷饮食疗法在非胰岛素治疗的2型糖尿病患者中的应用[J].医学研究与战创伤救治(原医学研究生学报),2014,16(05):469.[doi:10.3969/j.issn.1672-271X.2014.05.007]
　XIONG Xiao-qin,WANG Ai-min,LUO Jing,et al.The application of dietary glycemic load in non-insulin-treated type 2 diabetes[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2014,16(05):469.[doi:10.3969/j.issn.1672-271X.2014.05.007]
[10]薛 军,黄先涛,汤学勤.临床路径在医院的试点与应用价值分析[J].医学研究与战创伤救治(原医学研究生学报),2014,16(06):581.[doi:10.3969/j.issn.1672-271X.2014.06.007]
　XUE Jun,HUANG Xian-tao,TANG Xue-qin..Analysis of clinical pathway in the pilot and the value of application in our hospital[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2014,16(05):581.[doi:10.3969/j.issn.1672-271X.2014.06.007]

备注/Memo

备注/Memo:
南京军区医学科技创新经费资助项目(11MA124)
更新日期/Last Update: 2014-09-20